{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:12:40Z","timestamp":1779225160242,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Palliative sedation has become widely accepted as a method to alleviate refractory symptoms in terminally ill patients. Controversies regarding this topic especially concern the use of palliative sedation for psychological symptoms, the use in patients who are not imminently dying and the simultaneous withdrawal of life-sustaining measures. Amyotrophic lateral sclerosis (ALS) is characterized by symptoms including muscle weakness, dysphagia, dysarthria, muscle spasms and progressive respiratory insufficiency. Due to these characteristic symptoms, palliative sedation might be considered to be necessary to alleviate refractory suffering in ALS patients. However, palliative sedation in ALS is only rarely discussed in current medical literature and guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A questionnaire survey was conducted among neurologists and palliative care practitioners in Germany. The participants were asked to evaluate the use of palliative sedation in different situations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two hundred and ninety-six completed questionnaires were analyzed. The results suggest high levels of support for the use of palliative sedation in ALS patients. 42% of the participants stated that they had already used palliative sedation in the treatment of ALS patients. Acceptance of palliative sedation was higher in case of physical symptoms than in case of psychological symptoms. Refusal of artificial nutrition did not lead to a lower acceptance of palliative sedation. Doctors with specialist training in palliative care had already used palliative sedation in ALS patients more often and they were more likely to accept palliative sedation in different situations than the participants without a background in palliative care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our survey showed that palliative sedation in ALS is widely accepted by the attending doctors. In case of psychological symptoms, palliative sedation is looked at with more concern than in case of physical symptoms. The refusal of artificial nutrition does not result in a decreased acceptance of palliative sedation. Doctors with specialist training in palliative care are more likely to approve of palliative sedation in ALS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02681-7","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T07:02:45Z","timestamp":1651302165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Palliative sedation in amyotrophic lateral sclerosis: results of a nationwide survey among neurologists and palliative care practitioners in Germany"],"prefix":"10.1186","volume":"22","author":[{"given":"Laura","family":"Salzmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Alt-Epping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,30]]},"reference":[{"key":"2681_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/0269216309107024","volume":"23","author":"NI Cherny","year":"2009","unstructured":"Cherny NI, Radbruch L. The Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med. 2009;23:581\u201393.","journal-title":"Palliat Med"},{"key":"2681_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00481-010-0054-3","volume":"22","author":"G Neitzke","year":"2010","unstructured":"Neitzke G, Oehmichen F, Schliep HJ, W\u00f6rdehoff D. Sedierung am Lebensende. Empfehlungen der AG Ethik am Lebensende in der Akademie f\u00fcr Ethik in der Medizin (AEM). Ethik in der Medizin. 2010;22:139\u201347.","journal-title":"Ethik in der Medizin"},{"key":"2681_CR3","doi-asserted-by":"crossref","unstructured":"Kremling A, Bausewein C, Klein C, Schildmann E, Ostgathe C, Ziegler K, Schildmann J. Intentional Sedation as a Means to Ease Suffering: A Systematically Constructed Terminology for Sedation in Palliative Care, J Palliat Med, 2022;25:5.","DOI":"10.1089\/jpm.2021.0428"},{"key":"2681_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1089\/jpm.2011.0395","volume":"15","author":"B Jaspers","year":"2012","unstructured":"Jaspers B, Nauck F, Lindena G, Elsner F, Ostgathe C, Radbruch L. Palliative sedation in Germany: how much do we know? A prospective survey. J Palliat Med. 2012;15:672\u201380.","journal-title":"J Palliat Med"},{"key":"2681_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00481-004-0326-x","volume":"16","author":"HC M\u00fcller-Busch","year":"2004","unstructured":"M\u00fcller-Busch HC. \u201cTerminale Sedierung\u201d Ausweg im Einzelfall, Mittelweg oder schiefe Ebene? Ethik in der Medizin. 2004;16:369\u201377.","journal-title":"Ethik in der Medizin"},{"key":"2681_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-684X-6-4","volume":"6","author":"A Simon","year":"2007","unstructured":"Simon A, Kar M, Hinz J, Beck D. Attitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics. BMC Palliat Care. 2007;6:4.","journal-title":"BMC Palliat Care"},{"key":"2681_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00761-017-0240-8","volume":"23","author":"K Oechsle","year":"2017","unstructured":"Oechsle K, Radbruch L, Wolf C, Ostgathe C. SOP \u2013 Palliative Sedierung. Onkologe. 2017;23:469\u201375.","journal-title":"Onkologe"},{"key":"2681_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00481-008-0559-1","volume":"20","author":"A Simon","year":"2008","unstructured":"Simon A. Kommentar II. Ethik in der Medizin. 2008;20:138\u20139.","journal-title":"Ethik in der Medizin."},{"key":"2681_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/jpm.2013.0511","volume":"17","author":"E Schildmann","year":"2014","unstructured":"Schildmann E, Schildmann J. Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision making. J Palliat Med. 2014;17:601\u201311.","journal-title":"J Palliat Med"},{"key":"2681_CR10","doi-asserted-by":"crossref","unstructured":"Cellarius V. Terminal sedation and the \u201cimminence condition.\u201d J Med Ethics. 2008;34:69\u201372.","DOI":"10.1136\/jme.2006.019224"},{"key":"2681_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00481-004-0329-7","volume":"16","author":"G Neitzke","year":"2004","unstructured":"Neitzke G, Frewer A. Sedierung als Sterbehilfe?: Zur medizinethischen Kultur am Lebensende. Ethik in der Medizin. 2004;16:323\u201333.","journal-title":"Ethik in der Medizin"},{"key":"2681_CR12","first-page":"22","volume":"24","author":"D Orentlicher","year":"1997","unstructured":"Orentlicher D. The supreme court and terminal sedation: rejecting assisted suicide embracing euthanasia. Hastings Constit Law Q. 1997;24:22.","journal-title":"Hastings Constit Law Q"},{"key":"2681_CR13","doi-asserted-by":"crossref","unstructured":"Simon A. Entscheidungen am Lebensende. In: Erbguth F, Jox RJ, editors. Angewandte Ethik in der Neuromedizin. Berlin: Springer-Verlag; 2017.","DOI":"10.1007\/978-3-662-49916-0_20"},{"key":"2681_CR14","unstructured":"Ludolph AC, Anneser J. Die Amyotrophe Lateralsklerose und andere Motoneuronenerkrankungen. In: Brandt T, Diener HC, Gerloff C, editors. Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer; 2012."},{"key":"2681_CR15","unstructured":"Deutsche Gesellschaft f\u00fcr Neurologie, editor. Amyotrophe Lateralsklerose (Motoneuronerkrankung). 2015."},{"key":"2681_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) \u2013 revised report of an EFNS task force. Eur J Neurol. 2012;19:360\u201375.","journal-title":"Eur J Neurol"},{"key":"2681_CR17","unstructured":"Ludolph AC, Meyer T. Edaravone: eine neue Substanz f\u00fcr die Behandlung der ALS. DGN - Deutsche Gesellschaft f\u00fcr Neurologie. 2017. https:\/\/www.dgn.org\/neuronews\/54-neuronews-2017\/3436-edaravone-eine-neue-substanz-fuer-die-behandlung-der-als. Accessed 23 Apr 2020."},{"key":"2681_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpainsymman.2020.09.022","volume":"61","author":"M Arantzamendi","year":"2021","unstructured":"Arantzamendi M, Belar A, Payne S, Rijpstra M, Preston N, Menten J, et al. Clinical aspects of palliative sedation in prospective studies a systematic review. J Pain Symptom Manage. 2021;61:831-844.e10.","journal-title":"J Pain Symptom Manage"},{"key":"2681_CR19","first-page":"117822421881391","volume":"12","author":"DJ Oliver","year":"2019","unstructured":"Oliver DJ. Palliative care in motor neurone disease: where are we now? Palliat Care. 2019;12:117822421881391.","journal-title":"Palliat Care"},{"key":"2681_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-684X-6-4","volume":"6","author":"A Simon","year":"2007","unstructured":"Simon A, Kar M, Hinz J, Beck D. Attitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics. BMC Palliat Care. 2007;6:4.","journal-title":"BMC Palliat Care"},{"key":"2681_CR21","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1212\/WNL.0b013e3181d9edcb","volume":"74","author":"JA Russell","year":"2010","unstructured":"Russell JA, Williams MA, Drogan O. Sedation for the imminently dying: survey results from the AAN Ethics Section. Neurology. 2010;74:1303\u20139.","journal-title":"Neurology"},{"key":"2681_CR22","doi-asserted-by":"crossref","unstructured":"Lipuma SH. Continuous sedation until death as physician-assisted suicide\/euthanasia: a conceptual analysis. J Med Philo. 2013;38:jht005.","DOI":"10.1093\/jmp\/jht005"},{"key":"2681_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jpm.2000.3.313","volume":"3","author":"JL Hallenbeck","year":"2000","unstructured":"Hallenbeck JL. Terminal sedation: ethical implications in different situations. J Palliat Med. 2000;3:313\u201320.","journal-title":"J Palliat Med"},{"key":"2681_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-2005-837410","volume":"130","author":"B van Oorschot","year":"2005","unstructured":"van Oorschot B, Lipp V, Tietze A, Nickel N, Simon A. Einstellungen zur Sterbehilfe und zu Patientenverf\u00fcgungen: Ergebnisse einer Befragung von 727 \u00c4rzten. Dtsch med Wochenschr. 2005;130:261\u20135.","journal-title":"Dtsch med Wochenschr"},{"key":"2681_CR25","unstructured":"Weber M, Stiehl M, Reiter J, Rittner C. Ethische Entscheidungen am Ende des Lebens. Sorgsames Abw\u00e4gen der jeweiligen Situation. Ergebnisse einer \u00c4rztebefragung in Rheinland-Pfalz. Deutsches \u00c4rzteblatt. 2001;48:5."},{"key":"2681_CR26","unstructured":"Association for Palliative Medicine of Great Britain and Ireland, editor. Withdrawal of assisted ventilation at the request of a patient with motor neurone disease. 2015."},{"key":"2681_CR27","volume-title":"Principles of Biomedical Ethics","author":"TL Beauchamp","year":"2001","unstructured":"Beauchamp TL, Childress JF. Principles of Biomedical Ethics. New York: Oxford University Press; 2001."},{"key":"2681_CR28","unstructured":"Nationaler Ethikrat. Selbstbestimmung und F\u00fcrsorge am Lebensende. Stellungnahme. 2006."},{"key":"2681_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/21678421.2018.1536154","volume":"20","author":"T Thurn","year":"2019","unstructured":"Thurn T, Borasio GD, Chi\u00f2 A, Galvin M, McDermott CJ, Mora G, Sermeus W, Winkler AS, Anneser J. Physicians\u2019 attitudes toward end-of-life decisions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:74\u201381.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2681_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s00115-008-2439-9","volume":"79","author":"T Meyer","year":"2008","unstructured":"Meyer T, Dullinger JS, M\u00fcnch C, Keil J-P, Hempel E, Rosseau S, et al. Elektive Termination der Beatmungstherapie bei der amyotrophen Lateralsklerose. Nervenarzt. 2008;79:684\u201390.","journal-title":"Nervenarzt"}],"updated-by":[{"DOI":"10.1186\/s12883-022-02718-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000}}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02681-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T07:05:54Z","timestamp":1653289554000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02681-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02681-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12883-022-02718-x","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,30]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12883-022-02718-x","URL":"https:\/\/doi.org\/10.1186\/s12883-022-02718-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was exempted from an ethics review by the Ethics Committee of the University Medical Center Goettingen, Germany. We confirm that the need for a formal written consent was waived by the Ethics Committee. Nevertheless, in an accompanying letter participant were informed about the goal of the survey and the fact that participation is voluntary and data evaluation anonymous. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}